eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2015
vol. 19
 
Share:
Share:
abstract:
Review paper

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?

Tomasz Milecki
,
Andrzej Antczak
,
Zbigniew Kwias
,
Piotr Milecki

Contemp Oncol (Pozn) 2015; 19 (1): 1–5
Online publish date: 2015/03/26
View full text Get citation
 
PlumX metrics:
In recent years, significant development in the treatment of prostate cancer has taken place. One of the most documented methods of treatment in patients characterised by a high risk of progression is a combination of radiotherapy (RT) with long-term hormone therapy (HT). In this group of patients, neither RT alone nor HT alone allows satisfactory outcomes to be achieved, and therefore as monotherapy they are not recommended as optimal methods of treatment. In this review, we summarise arguments for combining radiotherapy with hormonal therapy in high-risk prostate cancer, with an emphasis on the results of phase III trials.
keywords:

prostate cancer, combination therapy, hormone therapy, radiotherapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.